$35.75
0.491.39%
At close: Dec 8, 4:00 PM EST
$35.75
N/A
After Hours: 4:28 PM EST
Comments
Loading...
NewAmsterdam Pharma Co Earnings Estimates, EPS & Revenue | NASDAQ:NAMS | Benzinga
NewAmsterdam Pharma Co reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 25
EPS Estimate
$-0.390
Quarterly Revenue Estimate
$4.33M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$35.24M
Analyze the earnings history of NewAmsterdam Pharma Co using advanced sorting and filters.
NewAmsterdam Pharma Co (NAMS) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-05 | $-0.61 | $-0.36 | -69.4 % |
| Q2 | 2025-08-06 | $-0.15 | $-0.46 | 67.4 % |
| Q1 | 2025-05-08 | $-0.34 | $-0.44 | 22.7 % |
| Q4 | 2025-02-26 | $-0.51 | $-0.47 | -8.51 % |
NewAmsterdam Pharma Co (NAMS) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-05 | $348.00K | $4.29M | -91.9 % |
| Q2 | 2025-08-06 | $19.15M | $2.23M | 756.6 % |
| Q1 | 2025-05-08 | $2.98M | $1.46M | 104.0 % |
FAQ
When is NewAmsterdam Pharma Co (NASDAQ:NAMS) reporting earnings?
NewAmsterdam Pharma Co (NAMS) is scheduled to report earnings on February 25, 2026. The last reported earnings were for reported on November 5, 2025 for Q3.
What were the latest earnings per share (EPS) for NewAmsterdam Pharma Co (NASDAQ:NAMS)?
The Actual EPS was $-0.61, which missed the estimate of $-0.36.
What were NewAmsterdam Pharma Co’s (NASDAQ:NAMS) revenues?
The Actual Revenue was $348K, which missed the estimate of $4.3M.
Browse earnings estimates, EPS, and revenue on all stocks.
